Literature DB >> 7552573

Parainfluenza virus type-3 infection attenuates the respiratory effects of antigen challenge in sensitized guinea pigs.

E M Kudlacz1, R W Knippenberg.   

Abstract

Respiratory viral infections not only exacerbate asthma symptoms but may also be important in the pathogenesis of the disease. We therefore explored the effects of respiratory viral infection on the respiratory response of sensitized guinea pigs to antigen challenge. Lung tissue obtained from uninfected guinea pigs sensitized to ovalbumin aerosol released histamine upon incubation with the antigen in vitro. After antigen challenge in vivo, sensitized animals had significantly greater numbers of eosinophils in their bronchoalveolar lavage fluid than did nonsensitized animals and exhibited airway hyperresponsiveness to methacholine aerosol. When ovalbumin sensitization was initiated 7 days after inoculation with parainfluenza virus type-3 (PI-3), antigen challenge elicited little histamine release from infected lung tissue in vitro. Likewise, subsequent to antigen challenge in vivo, animals failed to exhibit airway hyperresponsiveness or an increased eosinophil population in bronchoalveolar lavage fluid. Similar effects were observed when sensitization was begun 19 days after PI-3 virus inoculation. The mechanism(s) responsible for the attenuated responses to antigen in PI-3 infected animals are unknown but may involve virus-induced effects on immune cells.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7552573     DOI: 10.1007/bf01782019

Source DB:  PubMed          Journal:  Inflamm Res        ISSN: 1023-3830            Impact factor:   4.575


  24 in total

1.  Inhibition of antigen-induced late asthmatic response and bronchial hyperresponsiveness by cyclosporin and FK 506.

Authors:  T Fukuda; I Akutsu; S Motojima; S Makino
Journal:  Int Arch Allergy Appl Immunol       Date:  1991

Review 2.  Respiratory infections and asthma.

Authors:  U S Björnsdottir; W W Busse
Journal:  Med Clin North Am       Date:  1992-07       Impact factor: 5.456

3.  Mechanisms of bronchial hyperreactivity in normal subjects after upper respiratory tract infection.

Authors:  D W Empey; L A Laitinen; L Jacobs; W M Gold; J A Nadel
Journal:  Am Rev Respir Dis       Date:  1976-02

4.  Protective effects of cyclophosphamide, cyclosporin A and FK506 against antigen-induced lung eosinophilia in guinea-pigs.

Authors:  A A Norris; D M Jackson; R P Eady
Journal:  Clin Exp Immunol       Date:  1992-09       Impact factor: 4.330

5.  Infection and immunoregulation of T lymphocytes by parainfluenza virus type 3.

Authors:  S Sieg; C Muro-Cacho; S Robertson; Y Huang; D Kaplan
Journal:  Proc Natl Acad Sci U S A       Date:  1994-07-05       Impact factor: 11.205

6.  Effect of cyclosporin A and the platelet-activating factor (PAF) antagonist, BN 52021, on PAF- and antigen- induced bronchoconstriction in the guinea-pig.

Authors:  C Touvay; B Vilain; V Lejeune; J M Mencia-Huerta; P Braquet
Journal:  Biochem Biophys Res Commun       Date:  1989-08-30       Impact factor: 3.575

7.  Pharmacological modulation of immediate and late airway response and leukocyte infiltration in the guinea pig.

Authors:  T Matsumoto; Y Ashida; R Tsukuda
Journal:  J Pharmacol Exp Ther       Date:  1994-06       Impact factor: 4.030

8.  Defect in intracellular killing of Staphylococcus aureus within alveolar macrophages in Sendai virus-infected murine lungs.

Authors:  G J Jakab; G M Green
Journal:  J Clin Invest       Date:  1976-06       Impact factor: 14.808

9.  Predictive value of respiratory syncytial virus-specific IgE responses for recurrent wheezing following bronchiolitis.

Authors:  R C Welliver; M Sun; D Rinaldo; P L Ogra
Journal:  J Pediatr       Date:  1986-11       Impact factor: 4.406

Review 10.  Viruses as precipitants of asthma symptoms. II. Physiology and mechanisms.

Authors:  P G Bardin; S L Johnston; P K Pattemore
Journal:  Clin Exp Allergy       Date:  1992-09       Impact factor: 5.018

View more
  2 in total

1.  Respiratory syncytial virus infection results in airway hyperresponsiveness and enhanced airway sensitization to allergen.

Authors:  J Schwarze; E Hamelmann; K L Bradley; K Takeda; E W Gelfand
Journal:  J Clin Invest       Date:  1997-07-01       Impact factor: 14.808

Review 2.  The role of viruses in development or exacerbation of atopic asthma.

Authors:  J Schwarze; E W Gelfand
Journal:  Clin Chest Med       Date:  2000-06       Impact factor: 2.878

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.